APs	Antipsychotic drugs
SGFs	Second-generation antipsychotics
TGFs	Third-generation antipsychotics
BDNF	Brain-derived neurotrophic factor
FGAs	First-generation antipsychotics
SGAs	Second-generation antipsychotics
EPSs	Extrapyramidal symptoms
FDA	Food and Drug Administration
MDD	Major depressive disorder
GFs	Growth factors
GDNF	Glial cell line-derived neurotrophic factor
NT-3	Neurotrophin 3
NT-4	Neurotrophin 4
TrkA, TrkB, TrkC	Tropomyosin receptor kinase A, B, C
p75NTR	p75 neurotrophin receptor
NGF	Nerve growth factor
PSD	Postsynaptic density
IEG	Immediate early gene
PFC	Prefrontal cortex
fMRI	Functional magnetic resonance imaging
NET	Norepinephrine transporter
Hsp90	Heat shock protein 90
IP3	Inositol 1,4,5-triphosphate
DG	Dentate gyrus
5-HT2A	Serotonin receptor 2A
α2C	Alpha-2C Adrenergic Receptor
5-HT7	Serotonin receptor 7
M1	Muscarinic acetylcholine receptor M1
H1	Histamine receptor 1
α1A	Alpha-1A Adrenergic Receptor
α2A	Alpha-2A Adrenergic Receptor
Gfap	Glial fibrillary acidic protein
Psd95	Postsynaptic density protein 95
mTOR	Mammalian target of rapamycin
EEF2	Eukaryotic elongation factor 2
PD	Parkinson’s disease